Articles 2013

Allen DL, Metcalfe P, Kaplan C, Kekomäki R, de Haas M, Yusuf R, Ouwehand WH. Sensitivity of assays for the detection of HPA-1a antibodies: Results of an international workshop demonstrating the impact of cation chelation from integrin alphaIIbbeta3 on three widely used assays. Vox Sang. 2013;105(2):167-173. PM: 23662600

Aranko K, Partanen J, Le Texler L, Hadley A. The Role of blood establishments in cellular therapies: Intellectual property issues. in: Follea G, de Witt J. editors. Blood, tissues and cells from human origin: The European Blood Alliance perspective. 1.ed. Amsterdam: European Blood Alliance, 2013:312-320.

Eichler H, Schallmoser K. Strunk D, Nystedt J, Kaartinen T, Korhonen M, Fleury-Cappellesso S, Sensebe L, Bonig H, Rebulla P, Giordano R, Lecchi L, Takanashi M, Watt SM, Austin EB, Guttridge M, McLaughlin LS, Panzer S and Reesink HW. Donor selection and release criteria of cellular therapy products. Vox Sang 2013;104(1):67-91. PM: 23252690

Ekblom-Kullberg S, Kautiainen H, Alha P, Leirisalo-Repo M and Julkunen H. Smoking and the risk of systemic lupus erythematosus. Clin Rheumatol. 2013;32(8):1219-22. PM: 23515599

Ekblom-Kullberg S, Kautiainen H, Alha P, Leirisalo-Repo M, Julkunen H. Frequency of and risk factors for symptomatic bone fractures in patients with systemic lupus erythematosus. Scand J Rheumatol. 2013;42(5):390-93. PM: 23721483

Estcourt LJ, Heddle N, Kaufman R, McCullough J, Murphy MF, Slichter S, Wood EM, Stanworth SJ on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative(Kekomäki R) The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions. Transfusion. 2013;53(7):1531-43. PM: 23305609

Gonzalez-Galarza FF, Mack SJ, Hollenbach J, Fernandez-Vina M, Setterholm M, Kempenich J, Marsh SG, Jones AR, Middleton D and HLA Rare Allele Consortium. 16(th) IHIW: extending the number of resources and bioinformatics analysis for the investigation of HLA rare alleles. Int J Immunogenet. 2013;40(1):60-5. PM: 23198982

Haimila K, Penttilä A, Arvola A, Auvinen MK and Korhonen M. Analysis of the adequate size of a cord blood bank and comparison of HLA haplotype distributions between four populations. Hum Immunol. 2013;74(2):189-95. PM: 23137880

Haimila K, Peräsaari J, Linjama T, Koskela S, Saarinenl T, Lauronen J, Auvinen M- and Jaatinen T. HLA antigen, allele and haplotype frequencies and their use in virtual panel reactive antigen calculations in the Finnish population. Tissue Antigens. 2013;81(1):35-43. PM: 23216287

Hirvonen T, Suila H, Tiitinen S, Natunen S, Laukkanen M-L, Kotovuori A, Reinman M, Satomaa T, Alfthan K, Laitinen S, Takkinen K, Räbinä J, and Valmu L. Production of a Recombinant Antibody Specific for i Blood Group Antigen, a Mesenchymal Stem Cell Marker. Bioresearch Open Access 2013;4(5):336-45. PM: 24083089

Hyvärinen K, Tuomainen AM, Laitinen S, Alfthan G, Salminen I, Leinonen M, Saikku P, Kovanen PT, Jauhiainen M, Pussinen PJ: The effect of proatherogenic pathogens on adipose tissue transcriptome and fatty acid distribution in apolipoprotein E-deficient mice. BMC Genomics 2013;14(1):709. PM: 24131481

Ijäs P, Saksi J, Soinne L, Tuimala J, Jauhiainen M, Jula A, Kähönen M, Kesäniemi YA, Kovanen PT, Kasek M, Lindsberg PJ. Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events Atherosclerosis 2013: 230: 228-34. PM: 24075749

Ikonen L, Kerkelä E, Metselaar G, Stuart M, de Jong MR, Aalto-Setälä K. 2D and 3D Self-Assembling Nanofiber Hydrogels for Cardiomyocyte Culture. BioMed Research International 2013, 2013, 12 pages, article ID ID 285678

Jahnukainen T, Rautiainen P, Mattila IP, Puntila J, Haavisto A, Qvist E, Pihkala J, Peräsaari J, Merenmies J, Sairanen H, Jalanko H and Salminen JT. Outcome of pediatric heart transplantation recipients treated with ventricular assist device. Pediatr Transplant. 2013;17(1):73-9 PM: 23190354

Javela K, Engelbarth S, Hiltunen L, Mustonen P, Puurunen M. Great discrepancy in antithrombin activity measured using five commercially available functional assays. Thromb Res 2013;132(1):132-7. PM: 23768451

Juutistenaho S, Möttönen S, Eskola M, Aranko K, Kekomäki R. Growth of erythroid cells from thawed unseparated cord blood in vitro without exogenous erythropoietin. Transfus Apher Sci. 2013;49(2):193-99. PM: 23683500

Juvonen E, Krusius T. Veriturvatoiminta Suomessa. Kirjassa: Aaltonen L-M, Rosenberg P, toimittajat. Potilasturvallisuuden perusteet. 1. p. Helsinki: Duodecim, 2013:212-224

Juvonen E, Sareneva I, Krusius T. Verivalmisteita täsmälliseen verensiirtotarpeeseen. Suomen Lääkärilehti 2013;68(49):3227-30.

Juvonen E, Sainio S, Krusius T. Verensiirto: Käyttöaiheet, suoritus ja haitat. Sähköisessä oppikirjassa: Lääkärin käsikirja, Lääkärin tietokannat, Terveysportti, Duodecim 2013.

Kaukola T, Kallankari H, Tuimala J, Olsen P, Tammela O, Kingsmore SF, Hallman M. Perinatal immunoproteins predict the risk of cerebral palsy in preterm children. Ann Med 2013;45(1):57-65. PM: 22040034

Kaukonen KM, Vaara ST, Pettilä V, Bellomo R, Tuimala J, Cooper DJ, Krusius T, Kuitunen A, Reinikainen M, Koskenkari J, Uusaro A. Age of red blood cells and outcome in acute kidney injury. Crit Care 2013;17(5):R222. PM: 24093554

Kaukonen KM, Krusius T. Punasolujen iän vaikutus potilaan ennusteeseen. FINNANEST. 2013;46(4):314-320.

Kerkelä E, Hakkarainen T, Mäkelä T, Raki M, Kambur O, Kilpinen L, Nikkilä J, Lehtonen S, Ritamo I, Pernu R, Pietilä M, Takalo R, Juvonen T, Bergström K, Kalso E, Valmu L, Laitinen S, Lehenkari P, Nystedt J.Transient Proteolytic Modification of Mesenchymal Stromal Cells Increases Lung Clearance Rate and Targeting to Injured Tissue. Stem Cells Translational Medicine 2013;2(7):510-10 PM: 23734061

Kilpinen L, Tigistu-Sahle F, Oja S, Greco D, Parmar A, Saavalainen P, Nikkilä J, Korhonen M, Lehenkari P, Käkelä R and Laitinen S. Aging bone marrow mesenchymal stromal cells have altered membrane glycerophospholipid composition and functionality. J Lipid Res. 2013;54(3):622-35. PM: 23271708

Kilpinen L, Impola U, Sankkila L, Ritamo I, Aatonen M, Kilpinen S, Tuimala J, Valmu L, Levijoki J, Finckenberg P, Siljander P, Kankuri E, Mervaala E and Laitinen S. Extracellular membrane vesicles form umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning. J Extracellular Vesicles 2013;2:21927. PM: 24349659

Korhonen M and Jolkkonen J. Intravascular cell therapy in stroke patients: where the cells go and what they do. Regenerative Medicine. 2013;8(2):93-5.

Krusius T, Pastila S, Toiviainen E. Riittääkö verta tulevaisuudessa ? Vanhusväestön määrän kasvu lisää verivalmisteiden käyttöä. Mediuutiset 2013(14):8-9

Leymarie N, Griffin PJ, Jonscher K — Valmu L —et al. Interlaboratory Study on Differential Analysis of Protein Glycosylation by Mass Spectrometry: the ABRF Glycoprotein Research Multi-Institutional Study 2012. Mol Cell Proteomics, 2013;12(10):2935-51. PM: 23764502

Mikkola M, Toivonen S, Tamminen K, Alfthan K, Tuuri T, Satomaa T, Natunen J, Saarinen J, Tiittanen M, Lampinen M, Valmu L, Partanen J and Otonkoski T. Lectin from Erythrina cristagalli Supports Undifferentiated Growth and Differentiation of Human Pluripotent Stem Cells. Stem Cells Dev. 2013;22(5):707-16. PM: 23106381